Trial
Psychiatry

RECOVER: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment-Resistant Depression

Active recruiting

The RECOVER study is a nationwide clinical trial that has been approved by Medicare to provide additional evidence for the benefits of Vagus Nerve Stimulation (VNS) Therapy.  Vagus Nerve Stimulation Therapy is an FDA-approved device for treating patients with TRD (Treatment Resistant Depression). It is implanted in the left chest area during a short outpatient procedure. The device delivers mild, intermittently pulsed signals to the vagus nerve in the neck that activate various parts of the brain.

Contact: Oladele (Dickson) Owasoyo 217-545-7231
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
Trial
Neurology

Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

Active recruiting

ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.

Contact: Stephanie Kohlrus 217-545-3013
News

Report, Webinar Focuses on Impact of COVID-19 and the Rural Health Workforce

SPRINGFIELD, IL – A new report dissects the impact of COVID-19 on the rural health workforce and identifies methods the state can utilize current health workers more efficiently while committing to long-term rural health workforce recruitment strategies. “Pre-pandemic, rural regions suffered from significant healthcare provider shortages, which often required rural residents to travel long distances or wait longer for appointments,” said Dr. Sameer Vohra, Chair, SIU Medicine Department of Population Science and Policy. “Despite rural health workers’ heroic efforts during the pandemic, job
General Results

Denim and Diamonds Annual Event

General Results

Alana Knudson, PhD

Alana Knudson, PhD, serves as a Program Area Director in the Public Health Department at NORC at the University of Chicago and is the Director of NORC’s Walsh Center for Rural Health Analysis. Dr. Knudson has over 25 years of experience implementing and directing public health programs, leading health services and policy research projects, and evaluating program effectiveness. She has led projects funded by many federal agencies and private foundations. Dr. Knudson currently serves as the Project Director for the Rural Cohort Analysis of Rural Health Programs funded by the Federal Office of
News

Rural Health Summit: COVID-19 and Public Health Systems

SPRINGFIELD, IL – The future of rural public health requires investment in data systems and public health workforce as well as enhanced partnerships between health care providers and public health departments according to a new policy brief released by Rural Health Summit organizers, Southern Illinois University (SIU) Medicine Department of Population Science and Policy , SIU Paul Simon Public Policy Institute , The University of Illinois Chicago School of Public Health and the SIU Medicine Center for Rural Health and Social Service Development . Rural public health systems faced an avalanche
General Results

Institutional Review Board (IRB)

Overview The SIU Medicine Institutional Review Board (IRB) is responsible for reviewing proposed research that includes humans as subjects. This includes any study that is: (1) sponsored by Southern Illinois University School of Medicine; (2) conducted in any school of medicine facility; or (3) conducted by school of medicine faculty, staff, residents, or medical students. Research to be performed by a community-based investigator and/or research to be conducted in any school of medicine-affiliated hospitals or sites may also be reviewed by the IRB with the appropriate authorization agreements
Subscribe to Research